These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10578271)

  • 1. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; McAlister V; Calne RY; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2754. PubMed ID: 10578277
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade.
    Moffatt SD; Metcalfe SM
    Transplantation; 2000 Apr; 69(8):1724-6. PubMed ID: 10836388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506.
    Fujimura T; Yang XF; Soriano R; Ogawa T; Kobayashi M; Jiang H
    Transplant Proc; 1998 Jun; 30(4):1023-6. PubMed ID: 9636413
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral administration of alloantigen induces indefinite prolongation of MHC mismatched cardiac allografts.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):892. PubMed ID: 10083392
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
    He G; Kim OS; Thistlethwaite JR; Hart J; Siegel CT; Szot GL; Newell KA
    Transplant Proc; 1999; 31(1-2):1239-41. PubMed ID: 10083553
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model.
    Moffatt SD; McAlister V; Calne RY; Metcalfe SM
    Transplantation; 1999 May; 67(9):1205-8. PubMed ID: 10342309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thymus is essential for the development of operational tolerance induced by donor-specific transfusion plus anti-CD4 monoclonal antibody.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2067. PubMed ID: 11120069
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; McKenzie IF
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenic (MHC class II+) cells are able to induce unresponsiveness when delivered with anti-CD4 monoclonal antibody.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1998 Aug; 30(5):2450. PubMed ID: 9723533
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506.
    Richter MH; Zahn S; Kraus M; Mohr FW; Olbrich HG
    J Heart Lung Transplant; 2003 Oct; 22(10):1107-16. PubMed ID: 14550820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 14. Amplification of natural regulatory immune mechanisms for transplantation tolerance.
    Chen ZK; Cobbold SP; Waldmann H; Metcalfe S
    Transplantation; 1996 Nov; 62(9):1200-6. PubMed ID: 8932256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice.
    Akita K; Ogawa M; Mandel TE
    Cell Transplant; 1994; 3(1):61-73. PubMed ID: 7512875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne RY; Metcalfe SM
    Tissue Antigens; 1994 Mar; 43(3):155-62. PubMed ID: 7916496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope for successful xenografting by immunosuppression with monoclonal antibody against CD4, total lymphoid irradiation and cyclosporine. Six months' survival of hamster heart transplanted into rat.
    Kemp E; Dieperink H; Jensenius JC; Koch C; Larsen S; Madsen HH; Nielsen B; Starklint H; Steinbrüchel DA
    Scand J Urol Nephrol; 1990; 24(1):79-80. PubMed ID: 2320973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody.
    Niimi M; Takashina M; Shirasugi N; Hamano K; Esato K; Matsumoto K; Ikeda Y; Takami H; Kodaira S; Kameyama K
    Transplant Proc; 2000 Aug; 32(5):1040. PubMed ID: 10936342
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K; Lehmann M; Flye MW
    Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.